GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » EV-to-EBIT

Albert David (BOM:524075) EV-to-EBIT : 5.00 (As of May. 16, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Albert David EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Albert David's Enterprise Value is ₹4,333 Mil. Albert David's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹866 Mil. Therefore, Albert David's EV-to-EBIT for today is 5.00.

The historical rank and industry rank for Albert David's EV-to-EBIT or its related term are showing as below:

BOM:524075' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.84   Med: 5.98   Max: 19.85
Current: 5.01

During the past 13 years, the highest EV-to-EBIT of Albert David was 19.85. The lowest was 1.84. And the median was 5.98.

BOM:524075's EV-to-EBIT is ranked better than
90.1% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.74 vs BOM:524075: 5.01

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Albert David's Enterprise Value for the quarter that ended in Dec. 2023 was ₹5,571 Mil. Albert David's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹866 Mil. Albert David's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 15.55%.


Albert David EV-to-EBIT Historical Data

The historical data trend for Albert David's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David EV-to-EBIT Chart

Albert David Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.34 2.76 2.42 2.82 1.84

Albert David Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.39 1.84 4.49 2.68 6.43

Competitive Comparison of Albert David's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Albert David's EV-to-EBIT falls into.



Albert David EV-to-EBIT Calculation

Albert David's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4332.710/866.114
=5.00

Albert David's current Enterprise Value is ₹4,333 Mil.
Albert David's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹866 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert David  (BOM:524075) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Albert David's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=866.114/5571.044234
=15.55 %

Albert David's Enterprise Value for the quarter that ended in Dec. 2023 was ₹5,571 Mil.
Albert David's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹866 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert David EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Albert David's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David (BOM:524075) Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David (BOM:524075) Headlines

No Headlines